Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 17Leukemia 13Hodgkin Disease 13Myelodysplastic Syndromes 12Lymphoma 12Myeloproliferative Disorders 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Neoplasms, Plasma Cell 9Lymphoma, Non-Hodgkin 9Leukemia, Myeloid, Acute 8Lymphoma, Mantle-Cell 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Burkitt Lymphoma 6Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Congenital Abnormalities 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Neoplasms 4Graft vs Host Disease 4Anemia, Aplastic 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Recurrence 3Primary Myelofibrosis 3

Interventions

fludarabine 1Melphalan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Preleukemia × Alemtuzumab × Plasma cell × Clear all
NCT00943293 2014-03-17

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

University of Chicago

Phase 1 Terminated
1 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Myeloproliferative Disorders, Preleukemia, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡